îæ€çŽ¢
îæ€çŽ¢
î
Sonoma Pharmaceuticals Inc
SNOAîãŠã©ãããªã¹ãã«è¿œå
1.100USD
-0.100-8.33%
çµå€Â 10-30 16:00ïŒETïŒ
5.27Mæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
Sonoma Pharmaceuticals IncïŒSNOAïŒç®æšæ ªäŸ¡ïŒèŠéã
ç®æšæ ªäŸ¡
14.800USD+1198.25%
SNOA ã¢ããªã¹ãæšå¥šãã¬ã³ã
ä»æãSNOAã¯0件ã®ãè²·ããã0件ã®ãäžç«ïŒããŒã«ãïŒãã0件ã®ã売ããè©äŸ¡ãç²åŸããŸãããçŽè¿1ã¶æã«ãããSNOAã®ã¢ããªã¹ãå¹³åç®æšæ ªäŸ¡ã¯14.800ã§ãã
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
0
0
0
0
0
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
SNOA åæ¥è æ¯èŒã¢ããªã¹ãè©äŸ¡
æŽæ°æå»: Oct 29, 2026äŒç€Ÿå
匷åè²·ã
è²·ã
äžç«
売ã
匷å売ã
ã¢ããªã¹ã
Biogen Inc
BIIB
8
16
12
1
0
37
Amgen Inc
AMGN
4
9
19
3
1
36
Eli Lilly and Co
LLY
10
19
3
1
0
33
Vertex Pharmaceuticals Inc
VRTX
10
17
5
0
1
33
Alnylam Pharmaceuticals Inc
ALNY
7
17
8
0
0
32
AbbVie Inc
ABBV
8
18
6
0
0
32
Neurocrine Biosciences Inc
NBIX
13
14
4
0
0
31
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Merck & Co Inc
MRK
7
16
8
0
0
31
Bristol-Myers Squibb Co
BMY
5
6
18
1
0
30
財åäºæž¬
ã¢ããªã¹ãäºæ³ã«ãããšãFY2027Q1ã«çºè¡šãããEPS -0.086ã«ç¶ããSNOAã®FY2027Q2ã®EPSã¯-0.098ã«éããèŠéãã§ããçºè¡šãããå®çžŸå€ãšäºæ³ãæ¯èŒããŠãåçæ§ã®æšç§»ã確èªããŸãããã
EPS
åç
çŽå©ç
EBIT
äºæž¬å€
å®çžŸå€
FY2026Q3
FY2026Q4
FY2027Q1
FY2027Q2
äºæž¬å€
-0.30
-0.20
-0.30
-0.10
å®çžŸå€
-0.48
-0.33
-0.09
--
ãµãã©ã€ãº
-56.76%
-67.43%
+71.11%
--
ãããã質å
Sonoma Pharmaceuticals Inc ã®æ¬¡ã®ååæã®åçã¯ãããã§ãã?
îSonoma Pharmaceuticals Inc ã®äºæ³åç㯠5.29M ã§ãã
Sonoma Pharmaceuticals Inc ã®ç®æšæ ªäŸ¡ã¯ãããã§ãã?
îã¢ããªã¹ãã¯ãSonoma Pharmaceuticals Inc ã®ç®æšæ ªäŸ¡ã USD 14.80 ãšäºæ³ããæé«äºæ³ã¯ USD 14.80ãæäœäºæ³ã¯ USD 14.80 ãšäºæ³ããŠããŸãã
Sonoma Pharmaceuticals IncSNOA ã®æè¿ã® 1 æ ªåœããã®å©çã¯ã©ããªã£ãŠããŸãã?
îåžå Žäºæ³ã¯ USD -0.09 ã§ããããSonoma Pharmaceuticals IncSNOA ã®åååæã®äžæ ªåœããå©ç (EPS) 㯠USD -0.33 ã§ããã次ã®ååæã® EPS 㯠USD -0.10 ãšäºæ³ãããŸãã